1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. PDGFR
  4. PDGFR Inhibitors

PDGFR Inhibitors

PDGFR

PDGFRβ

PDGFRα

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PDGFR Inhibitors
Product Name PDGFR PDGFRβ PDGFRα Purity
Lenvatinib  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
99.87%
Regorafenib  
PDGFRβ, IC50: 22 nM
  ≥99.0%
Nintedanib  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.97%
Sunitinib  
PDGFRβ, IC50: 2 nM
  ≥98.0%
Famitinib  
PDGFRβ, IC50: 6.6 nM
 
Zeteletinib
PDGFR
   
Ponatinib    
PDGFRα, IC50: 1.1 nM
99.38%
Axitinib  
PDGFRβ, IC50: 1.6 nM
  99.94%
Pazopanib  
PDGFRβ, IC50: 84 nM
  99.77%
Crenolanib  
PDGFRβ, Kd: 3.2 nM
PDGFRα, Kd: 2.1 nM
99.72%
Sunitinib Malate  
PDGFRβ, IC50: 2 nM
  ≥99.0%
SU 5402  
PDGFRβ, IC50: 510 nM
  99.38%
Ripretinib    
PDGFRA
98.90%
Dovitinib  
PDGFRβ, IC50: 27 nM
PDGFRα, IC50: 210 nM
99.94%
Nintedanib esylate  
PDGFRβ, IC50: 65 nM
PDGFRα, IC50: 59 nM
99.93%
Cediranib  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
≥98.0%
Pazopanib Hydrochloride  
PDGFRβ, IC50: 84 nM
  99.84%
Lenvatinib mesylate  
PDGFRβ, IC50: 39 nM
PDGFRα, IC50: 51 nM
99.86%
CP-673451  
PDGFRβ, IC50: 1 nM
PDGFRα, IC50: 10 nM
99.65%
Linifanib  
PDGFRβ, IC50: 66 nM
  99.72%
ENMD-2076    
PDGFRα, IC50: 56.4 nM
99.12%
Telatinib    
PDGFRα, IC50: 15 nM
98.72%
Amuvatinib    
PDGFRαV561D, IC50: 40 nM
PDGFRαD842V, IC50: 81 nM
98.07%
Regorafenib Hydrochloride  
PDGFRβ, IC50: 22 nM
  ≥98.0%
SU14813  
PDGFRβ, IC50: 4 nM
  98.90%
Regorafenib monohydrate  
PDGFRβ, IC50: 22 nM
  99.96%
PP121
PDGFR, IC50: 2 nM
    99.08%
CHIR-124
PDGFR, IC50: 6.6 nM
    ≥95.0%
Tandutinib
PDGFR, IC50: 0.2 μM
    99.48%
Orantinib  
PDGFRβ, Ki: 8 nM
  98.80%
Ilorasertib hydrochloride  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
98.91%
TAK-593  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 4.3 nM
PDGFRαV561D, IC50: 1 nM
99.62%
TG 100801  
PDGFRβ, IC50: 13 nM
  ≥95.0%
PP58
PDGFR
    99.48%
Cediranib maleate  
PDGFRβ, IC50: 5 nM
PDGFRα, IC50: 36 nM
99.74%
Dovitinib lactate  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
99.96%
JI-101  
PDGFRβ
  99.43%
Methylnissolin
PDGFR, IC50: 10 μM
    99.64%
JNJ-10198409  
PDGFRβ, IC50: 4.2 nM
PDGFRα, IC50: 45 nM
≥99.0%
AZD2932  
PDGFRβ, IC50: 4 nM
  ≥98.0%
Toceranib phosphate  
PDGFRβ, Ki: 5 nM
  98.02%
Toceranib  
PDGFRβ, Ki: 5 nM
  96.25%
AC710  
PDGFRβ, Kd: 1 nM
PDGFRα, Kd: 1.3 nM
99.89%
(Z)-Orantinib  
PDGFRβ, IC50: 0.008 μM
  99.02%
Chiauranib  
PDGFRβ, IC50: 93 nM
PDGFRα, IC50: 1 nM
99.28%
Tyrphostin AG1296  
PDGFRβ
PDGFRα
99.25%
SU16f
PDGFR2, IC50: 140 nM
PDGFR1, IC50: 2.29 μM
PDGFRβ, IC50: 10 nM
  ≥99.0%
Tyrphostin AG1433  
PDGFRβ, IC50: 5 μM
  99.20%
Tyrosine kinase-IN-1    
PDGFRα, IC50: 4 nM
99.47%
SU14813 maleate  
PDGFRβ, IC50: 4 nM
  99.95%
Telatinib mesylate    
PDGFRα, IC50: 15 nM
99.46%
Tandutinib hydrochloride
PDGFR, IC50: 0.2 μM
    98.84%
GZD856 formic  
PDGFRβ, IC50: 136.6 nM
PDGFRα, IC50: 68.6 nM
98.06%
Hypothemycin  
PDGFRβ, Ki: 900 nM
PDGFRα, Ki: 1.5 μM
≥98.0%
SU4312
PDGFR
    98.19%
ENMD-2076 Tartrate    
PDGFRα, IC50: 56.4 nM
98.87%
PDGFRα kinase inhibitor 1  
PDGFRβ, IC50: 6115 nM
PDGFRα, IC50: 132 nM
99.90%
PD-161570
PDGFR, IC50: 310 nM
PDGFRβ, IC50: 262 nM
  99.04%
NVP-ACC789  
PDGFR-β, IC50: 1.4 μM
  99.94%
Ponatinib-d8    
PDGFRα, IC50: 1.1 nM
TG 100572  
PDGFRβ, IC50: 13 nM
 
Ilorasertib  
PDGFRβ, IC50: 13 nM
PDGFRα, IC50: 11 nM
≥98.0%
Dovitinib lactate hydrate  
PDGFRβ, IC50: 210 nM
PDGFRα, IC50: 27 nM
GZD856  
PDGFRβ, IC50: 136.6 nM
PDGFRα, IC50: 68.6 nM
Amuvatinib hydrochloride    
PDGFRαV561D, IC50: 40 nM
PDGFRαD842V, IC50: 81 nM
KG5  
PDGFRβ, Kd: 520 nM
PDGFRα, Kd: 300 nM
PD-089828  
PDGFR-β, IC50: 1.76 μM
PDGFR-β, Ki: 2.38 μM
 
Multi-kinase inhibitor 1
PDGFR
   
HG-7-85-01    
PDGFRα, IC50: 440 nM
Sunitinib-d10  
PDGFRβ, IC50: 2 nM
 
TG 100801 Hydrochloride  
PDGFRβ, IC50: 13 nM
 
AC710 Mesylate  
PDGFRβ, Kd: 1 nM
PDGFRα, Kd: 1.3 nM